First report of carbapenem-resistant Acinetobacter nosocomialis isolates harboring ISAba1-blaOXA-23 genes in Latin America

Journal of Clinical Microbiology

Volumn 51, Issue 8, 2013, Pages 2739-2741

  Teixeira, Aline Borges ^a   Martins, Andreza Francisco ^b   Barin, Juliana ^a   Hermes, Djuli Milene ^a   Pitt, Caroline Pormann ^a   Barth, Afonso Luis ^a,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Centro Estadual de Vigilância em Saúde CEVS   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; IMIPENEM; INTERNAL TRANSCRIBED SPACER; MEROPENEM;

ACINETOBACTER; ACINETOBACTER CALCOACETICUS; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PITTII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLA OXA 51 GENE; BROTH DILUTION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; GENE SEQUENCE; ISABA1 BLA OXA 23 GENE; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PSEUDOMONAS AERUGINOSA; SOUTH AND CENTRAL AMERICA; SPECIES IDENTIFICATION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BRAZIL; CARBAPENEMS; HUMANS;

EID: 84880592213     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00469-13     Document Type: Article

References (21)

1. Bergogne-Bérézin E, Towner KJ. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
2. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
3. Poirel L, Nordmann P. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12: 826-836.
4. Donald HM, Scaife W, Amyes SG, Young HK. 2000. Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44: 196-199.
5. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. 2006. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44:2974-2976.
6. Walther-Rasmussen J, Hoiby N. 2006. OXA-type carbapenemases. J. Antimicrob. Chemother. 57:373-383.
7. Boo TW, Walsh F, Crowley B. 2006. First report of OXA-23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic. J. Antimicrob. Chemother. 58:1101-1102.
8. Kim DH, Choi JY, Jung SI, Thamlikitkul V, Song JH, Ko KS. 2012. AbaR4-type resistance island including the blaOXA-23 gene in Acinetobacter nosocomialis isolates. Antimicrob. Agents Chemother. 56:4548-4549.
9. Lee YT, Kuo SC, Chiang MC, Yang SP, Chen CP, Chen TL, Fung CP. 2012. Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii. Antimicrob. Agents Chemother. 56:1124-1127.
10. Higgins PG, Lehmann M, Wisplinghoff H, Seifert H. 2010. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J. Clin. Microbiol. 48:4592-4594.
11. Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. 2005. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J. Clin. Microbiol. 43:1632-1639.
12. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SGB, Livermore DM. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27:351-353.
13. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL. 2006. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258:72-77.
14. CLSI. 2012. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. CLSI document M100- S22. Clinical and Laboratory Standards Institute, Wayne, PA.
15. Pagano M, Martins AF, Machado AB, Barin J, Barth AL. 2012. Carbapenem-susceptible Acinetobacter baumannii carrying the ISAba1 upstream blaOXA-51-like gene in Porto Alegre, southern Brazil. Epidemiol. Infect. 141:1-4.
16. Coelho JM, Turton JF, Shah-Afzal M, Livermore DM. 2006. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob. Agents Chemother. 56:756-758.
17. Dalla-Costa LM, Coelho JM, Souza HA, Castro M, Stier C, Bragagnolo KL, Rea-Neto A, Penteado-Filho SR, Livermore DM, Woodford M. 2003. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J. Clin. Microbiol. 41: 3403-3406.
18. Gales AC, Castanheira M, Jones RN, Sader HS. 2012. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn. Microbiol. Infect. Dis. 73:354-360.
19. Mostachio AK, Levin AS, Rizek C, Rossi F, Zerbini J, Costa SF. 2012. High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil. Int. J. Antimicrob. Agents 39:396-401.
20. Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC, SENTRY Participants Group (Latin America). 2004. SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz. J. Infect. Dis. 8:25-79.
21. Poirel L, Figueiredo S, Cattoir V, Carattoli A, Nordmann P. 2008. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob. Agents Chemother. 52:1252-1256.